|
Volumn 48, Issue 1, 2001, Pages 151-157
|
Preferential susceptibility of brain tumors to the antiangiogenic effects of an αv integrin antagonist
a a a a a b a |
Author keywords
Antiangiogenesis; Brain tumors; Integrin antagonist; Xenotransplantation
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
CD51 ANTIGEN;
CILENGITIDE;
CYCLO(ARGINYL BETA ALANYLASPARTYL DEXTRO PHENYLALANYLVALINE);
CYCLO(ARGINYLGLYCYL ALPHA ASPARTYL DEXTRO PHENYLALANYL N METHYLVALINE);
CYCLOPEPTIDE;
EMD 135981;
INTEGRIN;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ANIMAL CELL;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN TUMOR;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG MECHANISM;
GLIOBLASTOMA;
GROWTH INHIBITION;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MEDULLOBLASTOMA;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
|
EID: 0035149747
PISSN: 0148396X
EISSN: None
Source Type: Journal
DOI: 10.1097/00006123-200101000-00026 Document Type: Article |
Times cited : (241)
|
References (47)
|